Page last updated: 2024-08-23

gusperimus and Sensitivity and Specificity

gusperimus has been researched along with Sensitivity and Specificity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birck, R; Braun, C; Nemoto, K; Neumann, I; Newman, M; van der Woude, FJ; Waldherr, R; Yard, B	1

Other Studies

1 other study(ies) available for gusperimus and Sensitivity and Specificity

Article	Year
15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:1 Topics: Animals; Biopsy, Needle; Cyclophosphamide; Disease Models, Animal; Guanidines; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Mycophenolic Acid; Nephritis; Random Allocation; Risk Factors; Sensitivity and Specificity; Survival Rate	2006

Article

Year

15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:1

Topics: Animals; Biopsy, Needle; Cyclophosphamide; Disease Models, Animal; Guanidines; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Mice; Mice, Inbred Strains; Mycophenolic Acid; Nephritis; Random Allocation; Risk Factors; Sensitivity and Specificity; Survival Rate

2006